Neuromodulation Devices Market Growth, Demand, Trends, Size, Analysis, and Forecast by 2029
The global neuromodulation devices market is projected to grow at a CAGR of 9-11% over the next 5 years. Growth in this market is driven by increasing demand for non-invasive treatments for chronic pain, Parkinson’s disease, epilepsy, and depression, along with the expansion of neuromodulation applications for treating overactive bladder and movement disorders. Advances in device miniaturization, battery life improvements, and targeted therapy delivery systems are further boosting the market. Additionally, the rising geriatric population and the growing prevalence of neurological disorders are key contributors to the expanding market. To learn more about the research report, download a sample report.
Neuromodulation encompasses a range of devices such as spinal cord stimulators (SCS), deep brain stimulators (DBS), sacral nerve stimulators (SNS), and vagus nerve stimulators (VNS). These devices offer electrical or pharmaceutical modulation to specific parts of the nervous system, aimed at reducing pain, improving motor functions, or managing chronic conditions like incontinence. Neuromodulation technology has been evolving, with companies focused on delivering personalized and condition-specific therapies. This has led to increasing demand for innovative solutions across various therapeutic areas, contributing to the overall market growth.
To learn more about this report, download the PDF brochure
Growing Prevalence of Chronic Pain, Movement Disorders, and Technological Advances Fuel Neuromodulation Devices Market
The neuromodulation devices market is primarily driven by the growing prevalence of chronic pain, neurological disorders, and movement conditions. The surge in demand for non-invasive treatment options and the availability of advanced neuromodulation devices, such as rechargeable and implantable pulse generators, is further driving market expansion. Key players such as Medtronic, Boston Scientific, and Abbott have introduced products with enhanced functionalities, including extended battery life and closed-loop stimulation systems, that target specific conditions like epilepsy, Parkinson’s, and depression. Furthermore, technological innovations like MRI-compatible devices and real-time data feedback systems are paving the way for more sophisticated neuromodulation therapies.
The High Cost of Neuromodulation Devices and Treatments is One of the Major Restraints
A major challenge in the neuromodulation devices market is the high cost of devices and treatments, which limits patient access, particularly in emerging economies. Spinal cord stimulators, for example, can cost tens of thousands of dollars, excluding the expenses for surgery and follow-up care. This financial barrier impacts both healthcare providers and patients. Additionally, reimbursement challenges in certain regions further exacerbate the problem, as many insurance systems either provide limited coverage or exclude neuromodulation treatments altogether. These factors constrain market growth, despite the promising potential of these therapies to address chronic pain and neurological disorders.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
Key players in the global neuromodulation devices market include Medtronic, Boston Scientific, Abbott, LivaNova, NeuroPace, Nevro Corp, Soterix Medical, electroCore, Inc., Synapse Biomedical, and Nexstim; among others. Key strategies adopted by market players include product innovation/launch, partnerships, and acquisitions to strengthen their market position.
Neuromodulation Devices Market Scope
|
Report Scope |
Details |
|
Base Year Considered |
2023 |
|
Historical Data |
2022 – 2023 |
|
Forecast Period |
2024 – 2029 |
|
Growth Rate |
CAGR of 9-11% |
|
Segment Scope |
Product Type, Applications, and End User |
|
Regional Scope |
|
|
Key Companies Mapped |
Medtronic, Boston Scientific, Abbott, LivaNova, NeuroPace, Nevro Corp, Soterix Medical, electroCore, Inc., Synapse Biomedical, and Nexstim; among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Key Strategic Questions Addressed
-
What is the market size & forecast of the neuromodulation devices market?
-
What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the neuromodulation devices market?
-
What are the key trends defining the market?
-
What are the major factors impacting the market?
-
What are the opportunities prevailing in the market?
-
Which region holds the highest market share?
-
Which region is expected to witness the highest growth rate in the next 5 years?
-
Who are the major players in the market?
-
What are the key strategies adopted by market players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Global Neuromodulation Devices Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increasing demand for non-invasive treatments for chronic pain
- Advances in device miniaturization, battery life improvements, and targeted therapy delivery systems
- Drivers
- Market Dynamics
- Rising prevalence of neurological disorders
- Availability of funding for research on neurological disorders and their treatment
- Restraints/Challenges
- High cost of neuromodulation device and the procedures
- Complications associated with devices
- Opportunities
- Emerging markets
- Key Market Trends
- Industry Speaks
- Global Neuromodulation Devices Market Size & Forecast (2022-2029), By Product Type, USD Billion
- Introduction
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Electrical Stimulators
- Transcranial Magnetic Stimulators (TMS)
- Other Devices
- Global Neuromodulation Devices Market Size & Forecast (2022-2029), By Applications, USD Billion
- Introduction
- Chronic Pain
- Epilepsy
- Movement Disorders (Parkinson’s, Tremor)
- Migraine and Cluster Headaches
- Mental Disorders
- Urinary Incontinence
- GI Disorders
- Others
- Neuromodulation Devices Market Size & Forecast (2022-2029), By End User, USD Billion
- Hospitals and Clinics
- Specialized Pain Management and Neurology Centers
- Others
- Global Neuromodulation Devices Market Size & Forecast (2022-2029), By Region, USD Billion
- Introduction
- North America Neuromodulation Devices Market Size & Forecast (2022-2029), By Country, USD Billion
- US
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Canada
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- US
- Europe Neuromodulation Devices Market Size & Forecast (2022-2029), By Country, USD Billion
- UK
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Germany
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- France
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Italy
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Spain
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Europe
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- UK
- North America Neuromodulation Devices Market Size & Forecast (2022-2029), By Country, USD Billion
- Introduction
-
-
- Asia Pacific (APAC) Neuromodulation Devices Market Size & Forecast (2022-2029), By Country, USD Billion
- China
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Japan
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- India
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Asia Pacific
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- China
- Latin America (LATAM) Neuromodulation Devices Market Size & Forecast (2022-2029), USD Billion
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Middle East & Africa (MEA) Neuromodulation Devices Market Size & Forecast (2022-2029), USD Billion
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Asia Pacific (APAC) Neuromodulation Devices Market Size & Forecast (2022-2029), By Country, USD Billion
-
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Medtronic
- Boston Scientific
- Abbott
- LivaNova
- NeuroPace
- Nevro Corp
- Soterix Medical
- electroCore, Inc.
- Synapse Biomedical
- Nexstim
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
Hospitals, Clinics, Specialized Pain Management Centers, Neurology Centers
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
